ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,027,303 | -48.5% | 74,698 | -41.7% | 0.00% | 0.0% |
| Q2 2023 | $3,938,931 | +192.8% | 128,137 | +243.2% | 0.00% | 0.0% |
| Q1 2023 | $1,345,108 | +22.4% | 37,333 | +34.2% | 0.00% | 0.0% |
| Q4 2022 | $1,099,288 | +46.8% | 27,816 | +49.1% | 0.00% | – |
| Q3 2022 | $749,000 | +208.2% | 18,650 | +222.1% | 0.00% | – |
| Q2 2022 | $243,000 | -97.5% | 5,790 | -97.7% | 0.00% | -100.0% |
| Q1 2022 | $9,703,000 | -47.8% | 249,072 | -46.6% | 0.00% | -40.0% |
| Q4 2021 | $18,580,000 | -10.3% | 466,259 | -18.7% | 0.01% | -37.5% |
| Q3 2021 | $20,725,000 | +150.3% | 573,465 | +183.9% | 0.01% | +166.7% |
| Q2 2021 | $8,280,000 | -63.7% | 202,007 | -61.4% | 0.00% | -72.7% |
| Q1 2021 | $22,816,000 | +210.8% | 523,037 | +256.6% | 0.01% | +175.0% |
| Q4 2020 | $7,342,000 | +1201.8% | 146,691 | +994.7% | 0.00% | – |
| Q3 2020 | $564,000 | -72.6% | 13,400 | -68.4% | 0.00% | -100.0% |
| Q2 2020 | $2,060,000 | – | 42,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |